Loading
Life sciences · Journal article
Sexual Medicine · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Testosterone deficiency (TD) has been closely associated with systemic inflammation and metabolic disturbances. The C-reactive protein-albumin-lymphocyte (CALLY) index is a composite biomarker integrating inflammatory, nutritional, and immune parameters. However, its association with TD remains unclear. This study aimed to investigate the relationship between the CALLY index and TD in adult men. This multicenter cross-sectional study included 434 adult men recruited from urology and andrology outpatient clinics between December 2024 and February 2026. The CALLY index was calculated using serum albumin, lymphocyte count, and C-reactive protein levels. TD was operationally defined as a morning total testosterone (TT) concentration <300 ng/dL in the presence of relevant clinical symptoms. Calculated free testosterone (cFT) was estimated from TT, SHBG, and albumin using the Vermeulen equation, and cFT-based sensitivity analyses were performed. Multivariable logistic regression was performed after adjustment for age, body mass index, smoking status, alcohol use, regular exercise, hypertension, diabetes, total cholesterol, and triglycerides. Receiver operating characteristic (ROC) curve analysis was conducted to evaluate discriminative performance. Among the participants, 198 (45.6%) were classified as having TD. The prevalence of TD decreased progressively across increasing quartiles of the CALLY index (70.6% in Q1 vs. 23.2% in Q4; P <.001). After adjustment for demographic, lifestyle, metabolic factors, comorbidities, and SHBG, higher CALLY index values remained independently associated with lower odds of TD (adjusted OR = 0.779, 95% CI: 0.721-0.843, P <.001). Compared with Q1, the adjusted ORs for TD were 0.683 (95% CI: 0.531-0.873) for Q2, 0.497 (95% CI: 0.368-0.662) for Q3, and 0.360 (95% CI: 0.329-0.499) for Q4 (all P <.001). cFT increased significantly across CALLY quartiles (P <.001), and a cFT-based sensitivity analysis showed a consistent inverse association (adjusted OR = 0.851, 95% CI: 0.799-0.906, P <.001). The CALLY index demonstrated moderate discriminative ability for TD (AUC = 0.777), with an optimal cut-off value of 4.10 (sensitivity 64.6%, specificity 81.7%). These findings indicate that the CALLY index is associated with TD and provides moderate discrimination. It may serve as a readily accessible composite marker of the inflammatory and nutritional milieu associated with TD; however, external validation is required before any clinical application can be considered.